You need to login...
If you are not registered...
| Subscribe to Krixos Health: | |
|
or call us on: +43 (0)1 27 63 015 or email: subscribe@krixos.com |
|
Most viewed
- 1. Genetic characterization of Lynch syndrome germline variants in a LATAM cohort using a customized NGS gene panel
- 2. Are Some 'Low-Grade' Prostate Cancers More Deadly Than Thought?
- 3. Oncolytic virus therapy for cancer: what's been going on in 2025?
- 4. Bioinformatics-based prognostic value and in vitro functional validation of PTK6 in cutaneous melanoma
- 5. Copper metabolism and cuproptosis: broad perspectives in the treatment of hepatocellular carcinoma
- 6. Physical activity and glioblastoma: a paradigm shift in neuro-oncology therapy
- 7. AI-based breast cancer risk technology receives FDA Breakthrough Device designation
- 8. Redefining "normal": discovery of aneuploid epithelial cells in healthy breast tissue
- 9. Polyamine metabolism related gene index prediction of prognosis and immunotherapy response in breast cancer
- 10. BriaCell Adds UCLA Health as Key Site in Pivotal Phase 3 Breast Cancer Study
Last updated at 6:56 GMT
Hot News Makers
Health/Pharma Companies
-
2542.91
-
1415.16
-
1384.86
-
542.49
-
532.12
-
300.49
-
233.08
-
224.18
-
216.29
-
192.76
Drugs, Treatments, Trials
-
7018.61
-
4998.59
-
3303.60
-
1982.16
-
991.08
-
582.99
-
482.59
-
473.83
-
428.97
-
347.79
Last updated at 6:10 GMT
